Person:
ALTINOK SÜT, PELİN

Profile Picture
Status
Kurumdan Ayrılmıştır
Organizational Units
OrgUnit Logo
Organizational Unit
Job Title
First Name
PELİN
Last Name
ALTINOK SÜT
Name
Email Address
Birth Date

Filters

2011 - 201982020 - 20231
Reset filters

Settings

Search Results

Now showing 1 - 9 of 9
  • No Thumbnail Available
    PublicationMetadata only
    Pancreatic panniculitis as the first manifestation of the pancreatic involvement during the course of a gastric adenocarcinoma
    (2011-03-01T00:00:00Z) BEYAZIT, H.; Aydin, O.; DEMIRKESEN, C.; DERIN, D.; Sut, PELİN; EMRE, A.; MANDEL, N.; ALTINOK SÜT, PELİN
    Pancreatic panniculitis (PP) is a rare disease presenting during the course of pancreatic diseases such as acute and chronic pancreatitis, pancreatic carcinoma. There are also a few reports of PP associated with other carcinomas. We present a 69-year-old male patient of gastric carcinoma with PP. The literature is reviewed, clinical and histological features of the case are discussed. This is the first case of PP in a gastric carcinoma patient reported in literature. As a conclusion, PP can be the first manifestation of a pancreatic metastasis of any carcinoma.
  • No Thumbnail Available
    PublicationMetadata only
    Tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer: A single center study.
    (2014-05-20T00:00:00Z) NAMAL, Esat; Sut, PELİN; ASKAROGLU, Bulent; YILDIZ, Betul; PAMUKCU, Ozgul; ALTINOK SÜT, PELİN
  • No Thumbnail Available
    PublicationMetadata only
    Pain management with Radiotherapy and ozone with high dose vitamin C therapy in a case of bone metastatis of breast cancer patient
    (2018-02-01) KIRSEVER, ESRA; KIZILTAN, HURİYE ŞENAY; YILMAZ, RABİYE; GÜNEŞ BAYIR, AYŞE; BAŞIBÜYÜK, MERYEM; ÇAKIR, FATMA BETÜL; GÜL, KÜRŞAT; ŞİMŞEK, MUHARREM; KIZILTEPE, AYŞE; GÜMÜŞ, ASLI; KALAYCI, KÜBRA; AKÇAKAYA, ADEM; MAYADAĞLI, ALPASLAN; AYDOĞDU, İBRAHİM; ALTINOK SÜT, PELİN; AYDIN, TEOMAN; KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMET; GÜNEŞ BAYIR, AYŞE; BAŞIBÜYÜK, MERYEM; ÇAKIR, FATMA BETÜL; GÜL, KÜRŞAT; GÜMÜŞ, ASLI; KALAYCI, KÜBRA; AKÇAKAYA, ADEM; MAYADAĞLI, ALPASLAN; AYDOĞDU, İBRAHİM; ALTINOK SÜT, PELİN; AYDIN, TEOMAN
  • Thumbnail Image
    PublicationOpen Access
    Merkel Cell Carcinoma
    (2023-01-01) Sönmez Ergün, Selma ; Kirazoğlu, Ahmet; Akdemir, Osman Cemil; Su Küçük, Özlem; Altınok, Pelin; Yıldız, Pelin; ERGÜN, SELMA; AKDEMİR, OSMAN CEMİL; KİRAZOĞLU, AHMET; YILDIZ, PELİN; SU KÜÇÜK, ÖZLEM; ALTINOK SÜT, PELİN
    Merkel cell carcinoma (MCC) is a rare tumor that arises from mechanoreceptor Merkel cells. Ultraviolet exposure, immunosuppression and Merkel cell polyoma virus play a significant role in tumor pathogenesis. Although it typically presents as an initially indolent growing, painless solitary lesion, the course of MCC may be aggressive due to the nodal invasion, distant metastasis and high recurrence rates. We presented a case of MCC with a background history of rheumatoid arthritis treated with immunosuppressive therapy for many years who had necrotizing granulomatous lymphadenitis.
  • No Thumbnail Available
    PublicationMetadata only
    Anaplastic thyroid carcinoma with diffuse thoracic skin metastasis: A case report
    (2014-06-01T00:00:00Z) ALTINAY, Serdar; TAS, Betul; OZEN, Aynur; Sut, PELİN; ALTINOK SÜT, PELİN
    Anaplastic thyroid carcinoma is a significantly fatal endocrine neoplasm, with an average survival time of 4-12 months following diagnosis. The present study reports the case of a 57-year-old male patient who presented to the Bagcilar Training and Research Hospital (Istanbul, Turkey) due to swelling in the neck and difficulty swallowing. The jugular mass biopsy results were consistent with a diagnosis of anaplastic thyroid cancer. The patient was regarded to have advanced-stage subcarinal, paratracheal, aortopulmonary, trancheobronchial and mediastinal lymphadenopathies and exhibited a good prognosis following chemotherapy. However, the patient succumbed one month later due to the emergence of diffuse skin lesions. The histopathological and immunohistochemical assessment of the skin biopsy displayed the characteristics of the underlying thyroid carcinoma.
  • No Thumbnail Available
    PublicationMetadata only
    Düşük doz radyoterapi volümlerinin akciğer kanseri hastalarında yaşam üzerine etkileri
    (2017-07-01) KIZILTAN, HURİYE ŞENAY; MAYADAĞLI, ALPASLAN; ERİŞ, ALİ HİKMET; KABLAN, ÖZGÜR; EROĞUZ, SEZGİ TURAN; EVRİM, EVREN; ALTINOK SÜT, PELİN; TEKÇE, ERTUĞRUL; GÜNEŞ BAYIR, AYŞE; KIRSEVER, ESRA; KIZILTAN, HURİYE ŞENAY; MAYADAĞLI, ALPASLAN; ERİŞ, ALİ HİKMET; KABLAN, ÖZGÜR; ALTINOK SÜT, PELİN; TEKÇE, ERTUĞRUL; GÜNEŞ BAYIR, AYŞE
  • No Thumbnail Available
    PublicationMetadata only
    Diş CBCT ile oluşan tiroid üzerindeki radyasyon doz etkisinin gösterilmesi
    (2018-02-01) ERİŞ, ALİ HİKMET; KIZILTAN, HURİYE ŞENAY; KABLAN, ÖZGÜR; TEKÇE, ERTUĞRUL; BERK, KEMAL; ÜNVER, TUBA; MAYADAĞLI, ALPASLAN; AYDIN, TEOMAN; ŞİMŞEK, CEREN; AKSOY, DİRENÇ ÖZLEM; BİLGİN, SABRİYE ŞENNUR; ERİŞ, ALİ HİKMET; KIZILTAN, HURİYE ŞENAY; KABLAN, ÖZGÜR; TEKÇE, ERTUĞRUL; ALTINOK SÜT, PELİN; MAYADAĞLI, ALPASLAN; AYDIN, TEOMAN; AKSOY, DİRENÇ ÖZLEM
  • No Thumbnail Available
    PublicationMetadata only
    Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer
    (2016-12-01T00:00:00Z) Ekici, Kemal; Pepele, Eda K.; Yaprak, Bahaddin; Ternelli, Oztun; Eraslan, Aysun F.; Kucuk, Nadir; Altinok, Ayse Y.; Sut, Pelin A.; ALPAK, Ozlem D.; ÇOLAK, CEMİL; Mayadagli, ALPASLAN; ALTINOK SÜT, PELİN; MAYADAĞLI, ALPASLAN
    Various radiotherapy planning methods for T1N0 laryngeal cancer have been proposed to decrease normal tissue toxicity. We compare helical tomotherapy (HT), linac-based intensity-modulated radiation therapy (IMRT), volumetric-modulated arc therapy (VMAT), and 3-D conformal radiotherapy (3D-CRT) techniques for T1N0 laryngeal cancer. Overall, 10 patients with T1N0 laryngeal cancer were selected and evaluated. Furthermore, 10 radiotherapy treatment plans have been created for all 10 patients, including HT, IMRT, VMAT, and 3D-CRT. IMRT, VMAT, and HT plans vs 3D-CRT plans consistently provided superior planning target volume (PTV) coverage. Similar target coverage was observed between the 3 IMRT modalities. Compared with 3D-CRT, IMRT, HT, and VMAT significantly reduced the mean dose to the carotid arteries. VMAT resulted in the lowest mean dose to the submandibular and thyroid glands. Compared with 3D-CRT, IMRT, HT, and VMAT significantly increased the maximum dose to the spinal cord It was observed that the 3 IMRT modalities studied showed superior target coverage with less variation between each plan in comparison with 3D-CRT. The 3D-CRT plans performed better at the Dmax of the spinal cord. Clinical investigation is warranted to determine if these treatment approaches would translate into a reduction in radiation therapy-induced toxicities. (C) 2016 American Association of Medical Dosimetrists.
  • No Thumbnail Available
    PublicationMetadata only
    Can low-dose radiotherapy volumes be one of the contributing factors to early relapses in lung cancer patients?
    (2018-03-01T00:00:00Z) Kiziltan, Huriye Senay; MAYADAĞLI, Alpaslan; TEKÇE, ERTUĞRUL; ERİŞ, ALİ HİKMET; Kablan, Ozgur; Altinok Sut, Pelin; KIZILTAN, HURİYE ŞENAY; MAYADAĞLI, ALPASLAN; TEKÇE, ERTUĞRUL; ERİŞ, ALİ HİKMET; KABLAN, ÖZGÜR; ALTINOK SÜT, PELİN
    © 2018 The Authors. Precision Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Shandong Cancer Hospital & Institute.Objective: Several studies have shown that low-dose radiotherapy (RT) might increase tumor invasion and metastases. Whereas multiple RT fields that increase low-dose RT areas are often used to prevent damage to organs at risk. We carried out a clinical trial with the concern that low-dose RT sites could increase invasions or metastases when multiple sites were used. Methods: A clinical retrospective study was carried out on 50 lung cancer patients with stage II–IIIB cancer, who underwent RT and/or chemotherapy, had Eastern Cooperative Oncology Group performances 1–3, were aged 45–87 years, and without metastases. RT was carried out for 5 days with 180–200 cGy fractions per day with a total dose of 54–66 Gy. The radiation dose volume areas V5, V10, V20, V40, V50, and V60 of lung were calculated and analyzed by Mann–Whitney U-test and L par test on disease-free and overall survival statistically. Results: It was determined that V5, V10, and V20, which constitute the low RT dose areas of the lung, positively affected the recurrence-free and overall survival minimally according to r correlation values. Conclusion: Low-dose RT volumes were positively affected minimally by recurrence-free survival and overall survival in the present study. The effects of low-dose radiation must be evaluated more clearly in studies.